Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 265486 | ||
| 1:21 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Pharmaceuticals Extends Tender Offer for a Portion of its Debt
Enzon Reports Third Quarter 2007 Results
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --
Enzon Pharmaceuticals to Add New Independent Director to Board

Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
Enzon Reveals New LNA Targets
-- Data will be presented at upcoming American Association for Cancer Research Meeting--
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors
Enzon Pharmaceuticals to Add New Independent Director to Board
